Black Diamond Therapeutics (BDTX) revealed Loss for fourth quarter that decreased from last year and beat the Street estimates.
The company's earnings came in at -$15.99 million, or -$0.28 per share. This compares with -$19.41 million, or -$0.34 per share, last year.
Analysts on average had expected the company to earn -$0.33 per share. Analysts' estimates typically exclude special items.
Black Diamond Therapeutics earnings at a glance (GAAP) :
-Earnings: -$15.99 Mln. vs. -$19.41 Mln. last year.
-EPS: -$0.28 vs. -$0.34 last year.
For comments and feedback: editorial@rttnews.com